Microemulsion Technology provides Podiatrists with better penetration and better results. With small particle size Formula 7®’s antibacterial and antifungal properties deliver the benefit of multiple products in a single tube or jar. The leader in Tolfnaftate Technology since 1986! Formula 7®is the first tolnaftate microemulsion utilizing soluble tolnaftate, the technology developed by the Tetra Corporation.
Total Ancillary provides multiple skin substitute products in one vendor, a revolutionary software portal to manage the process, and world-class customer service. Providers using Total Ancillary for biologics (1) Have More Covered Product Options to offer their patients, (2) Treat More Patients More Confidently, and (3) Promote Superior Clinical Outcomes versus traditional wound care.
Threats to private practice success include an increase in administrative burdens and IT costs.
Editor’s note: Check out the digital edition of APMA News for expert advice on how to minimize your risk of a ransomware attack, as well as cyber liability policy options.
Power Diary now includes a complete Practice Operations Manual providing a set of policies and procedures that practices can configure to meet their businesses' needs, set standards for the workplace, and maintain professional operations. Developed by a team with over 50 years of industry experience, this game-changing feature is available exclusively to all Power Diary customers!
Short-term funding options include line of credit and invoice factoring.
Editor’s note: Check out APMA’s “How To Be Your Own Boss” resources for advice on securing your finances and more. Learn the unexpected benefits of a longer loan term at www.apma.org/longerloan (Content provided by APMA's affinity partner Bankers Healthcare Group [BHG]).
